MyFinsight
Home
Blog
About
Hepion Pharmaceuticals, Inc. (HEPA)
Hepion Pharmaceuticals, Inc. (HEPA)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$973,955
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from the issuance of co...
Change in fair value of derivati...
Accounts payable and accrued exp...
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other asset...
Equity issuance costs
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net increase (decrease) in cash
-
-
-493,016
-
Investment in related party receivable
-
-
0
0
Effect of exchange rates on cash
-
-
0
0
Depreciation
-
-
0
0
Amortization of debt discount
-
-
0
0
Inducement expense
-
-
0
0
Write-off related party note receivable
-
-
0
-
Change in fair value of contingent consideration
-
-
0
0
Right of use asset
-
-
0
0
Operating lease liability
-
-
0
0
Asset impairment loss
-
-
0
0
Stock-based compensation
-
-
0
0
Net loss
-1,248,237
-810,791
-656,885
-472,506
Change in fair value of derivative financial instrumentswarrants
42,989
10,153
34,620
-47,275
Accounts payable and accrued expenses
7,187
240,255
112,217
-88,093
Prepaid expenses and other assets
195,894
-1,138,967
-177,273
-161,911
Net cash used in operating activities
-1,393,955
578,584
-332,775
-445,963
Investment in related party receivable
-
-
0
-
Investment in license agreement
-
-
0
0
Investment in license agreement
-
-
0
-
Net cash used in investing activities
-
-
0
0
Net cash used in investing activities
-
-
0
-
Subscription liability
-
250,000
0
0
Proceeds from the issuance of common stock and warrants, net
700,000
-
0
0
Equity issuance costs
30,000
-
0
0
Payments on notes payable
0
54,066
160,241
157,354
Net cash provided by financing activities
420,000
195,934
-160,241
-157,354
Net increase (decrease) in cash
-973,955
774,518
-493,016
-603,317
Cash at beginning of period
2,602,580
1,828,062
2,321,078
406,408
Cash at end of period
1,628,625
2,602,580
1,828,062
2,321,078
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of common stock...
$700,000
(-92.22%↓ Y/Y)
Net cash provided by
financing activities
$420,000
(-91.83%↓ Y/Y)
Canceled cashflow
$280,000
Net increase
(decrease) in cash
-$973,955
(-138.68%↓ Y/Y)
Canceled cashflow
$420,000
Change in fair value of
derivative financial...
$42,989
(-98.95%↓ Y/Y)
Accounts payable and
accrued expenses
$7,187
(131.67%↑ Y/Y)
something is missing
-$250,000
Equity issuance costs
$30,000
(-96.26%↓ Y/Y)
Net cash used in
operating activities
-$1,393,955
(44.08%↑ Y/Y)
Canceled cashflow
$50,176
Net loss
-$1,248,237
(82.54%↑ Y/Y)
Prepaid expenses and
other assets
$195,894
(228.51%↑ Y/Y)
Buy us a coffee